comparemela.com

Stage Assets News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Ligand Holds Investor and Analyst Day; Provides Update on Portfolio Progress and Recent Transactions; Introduces 2024 Guidance

12.12.2023 - Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) hosted an Investor and Analyst Day in New York City earlier today. CEO Todd Davis and other members of Ligand’s senior management team provided an overview of the company’s business model and . Seite 1

United statesNew yorkTodd davisVerona pharmaLigand pharmaceuticals incorporatedLigand holds investorAnalyst dayProvides updatePortfolio progressRecent transactionsPharmaceuticals incorporatedNew york cityStage assetsViking therapeuticMarinus pharmaceuticalTravere therapeutic

Midatech Pharma : Biodexa Pharmaceuticals PLC?Annual Report 2022Biodexa Pharmaceuticals PLC(formerly Midatech Pharma Plc)Annual Report 2022 - Form 6-K

Biodexa Pharmaceuticals PLC?Annual Report 2022Biodexa Pharmaceuticals PLCAnnual Report 2022 . | June 1, 2023

United statesSan franciscoNoord hollandNew yorkCity ofUnited kingdomBruxelles capitaleRepublic of irelandRussian federationMidatech pharmaTechnologiesq spheraourq spheraStephen parkerMidatech pharma ptydissolvedExecutivestephen parkernonDaniel palmer phdviceMidasolvepanobinostatrecurrent gbmdirect

Top Life Sciences Startups to Watch in 2023

BioSpace is proud to present its NextGen Bio “Class of 2023,” a list of the hottest recently launched life sciences companies in North America.

United statesUnited kingdomLos altosSan diegoSouth san franciscoSan franciscoBasecamp lentipeakStanley qiLiz bhattBio vectorselectJeff bezosEli lillyBiospace nextgen bioNextgen bioJean christophe harmangeLuke gilbert

vimarsana © 2020. All Rights Reserved.